Cargando…
Effects of arsenic trioxide combined with platinum drugs in treatment of cervical cancer: A protocol for systematic review and meta-analysis of randomized controlled trials
INTRODUCTION: Cervical cancer is the second largest tumor disease threatening female reproductive tract health. AS2O3 is a multi-directional and multi-target anti-cervical cancer drug. It can be combined with platinum drugs to treat cervical cancer. The literatures of AS2O3 combined with platinum dr...
Autores principales: | Zhang, Yawen, Pan, Di, Yang, Haishi, Huang, Jiaxin, He, Zeyang, Li, Haiying, Li, Daocheng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7647570/ https://www.ncbi.nlm.nih.gov/pubmed/33157935 http://dx.doi.org/10.1097/MD.0000000000022950 |
Ejemplares similares
-
Anlotinib combined with etoposide for platinum-resistant recurrent ovarian cancer: A case report
por: Sun, Li, et al.
Publicado: (2020) -
Apatinib combined with chemotherapy or concurrent chemo-brachytherapy in patients with recurrent or advanced cervical cancer: A phase 2, randomized controlled, prospective study
por: Guo, Qiufen, et al.
Publicado: (2020) -
Bevacizumab combined with chemotherapy for ovarian cancer: A protocol for systematic review and meta-analysis
por: Liao, Ting, et al.
Publicado: (2021) -
Transvaginal ultrasound cervical length for prediction of spontaneous labor at term: A protocol for systematic review and meta-analysis
por: Wu, Lirong, et al.
Publicado: (2020) -
Effect of neoadjuvant chemotherapy on platinum resistance in stage IIIC and IV epithelial ovarian cancer
por: Luo, Yanlin, et al.
Publicado: (2016)